About Kalderos
Kalderos is a healthcare technology company that built the industry's first Drug Discount Management platform, offering a cloud-based, AI- and machine learning-powered solution to monitor, validate, and resolve drug discount disputes. It serves drug manufacturers, healthcare providers, payers, state Medicaid programs, and government agencies to improve compliance, transparency, and efficiency across drug discount programs such as 340B. In June 2026, Kalderos was acquired by Model N.
Company details
Funding
Total raised
$76.3M
Last stage
Series C
Investors
Founders
David De Vogel
Co-founder of Kalderos, listed on Tracxn and confirmed as one of the three founders.
Jim Bonkowski
Co-founder of Kalderos, listed on Tracxn and CB Insights as a founder of the company.
Jeremy Docken
Co-founder of Kalderos; served as CEO through at least the Series B in 2020; later held CSO role. Publicly credited in multiple press releases and news articles.
LinkedInJames William Schuyler
Co-founder of Kalderos, listed as Chief Design Officer in company records.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.